Mostrando 22,921 - 22,940 Resultados de 23,176 Para Buscar '"anemia"', tiempo de consulta: 0.50s Limitar resultados
  1. 22921
    “…There were no intergroup differences with most prevalent comorbidities at admission including hypertension (99%), diabetes (41%), chronic pulmonary disease (37%), obesity (36%), deficiency anemia (31%), and renal failure (25%). There were no intergroup differences in initiation of COVID-19 directed treatments. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 22922
  3. 22923
    “…RESULTS: In HFpEF with T2DM compared with HFpEF without T2DM and the controls, the prevalence of sarcopenia, chronotropic incompetence, and anemia were significantly higher (p < 0.001). The peakVO(2) (Controls 23.5 vs. without T2DM 15.1 vs. with T2DM 11.6 mL/min/kg), peak HR (Controls 164 vs. without T2DM 132 vs. with T2DM 120 bpm/min), peak a-vO(2) (Controls 13.1 vs without T2DM 10.6 vs with T2DM 8.9 mL/100 mL), and VE vs VCO(2) slope (Controls 33.2 vs without T2DM 35.0 vs with T2DM 38.2) were significantly worsened in patients with HFpEF with T2DM (median, p < 0.001). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 22924
    “…Diarrhea, local abdominal pain, and hematochezia occur with the development of cancer, while systemic symptoms such as anemia and weight loss occur in patients with advanced CRC. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 22925
    “…The younger than 50 years group had a significantly higher incidence of nausea and vomiting (69.3% vs 57.6% [50-65 years] vs 60.4% [>65 years]; P = .02), severe abdominal pain (8.4% vs 3.4% vs 3.5%; P = .02), severe anemia (6.1% vs 1.0% vs 1.5%; P < .001), and severe rash (2.8% vs 1.2% vs 0.4% P = .047). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 22926
    “…The most common grade 3 or 4 adverse events(AE) were leucopenia (25.0%), neutropenia (17.5%), anemia (10.0%), thrombocytopenia (5.0%), hyponatremia (2.5%), and pneumonia(2.5%). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 22927
    “…The most commonly occurring hematologic AE of any grade was anemia (38.1%). The most frequent nonhematologic AEs of any grade were peripheral neuropathy (38.1%), dyspepsia (23.8%), constipation (23.8%), and alopecia (23.8%). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 22928
  9. 22929
    “…Most of TRAE were Gr 1-2, and only 3 pts (13.6%) experienced ≥ Gr3 TRAE (anemia, fatigue and pneumonitis) without treatment discontinuation and death caused by KN026. 4 of 21 pts (1 at 10mg/kg, 2 at 20 mg/kg, 1 at 30mg/kg) achieved objective response (ORR 19.0%, 95% CI: 5.5, 41.9), and DCR was 61.9% (95% CI: 38.4, 81.9). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 22930
    “…BACKGROUND: Epoetin alfa and darbepoetin alfa are erythropoiesis-stimulating agents (ESAs) indicated for the treatment of anemia in chronic renal failure, including patients on dialysis and patients not on dialysis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 22931
    “…PURPOSE: Transfusing red blood cells promptly corrects anemia and improves tissue oxygenation in around 40% of patients hospitalized in the intensive care unit (ICU) after major surgical operations. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 22932
  13. 22933
    “…Similar intergroup comorbidities included hypertension (56%), iron deficiency anemia (23%), chronic pulmonary disease (21%), neurological disease (21%), renal failure (19%), coagulation disease (16%), and heart failure (15%). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 22934
    “…•Intergroup distribution of comorbidities included HTN (63%, 83%, 75%, 87%), iron deficiency anemia (47%, 48%, 47%, 54%), neurological disease (47%, 46%, 51%, 49%), heart failure (30%, 42%, 35%, 44%), renal failure (22%, 44%, 28%, 41%), coagulation disease (37%, 33%, 37%, 30%) and chronic pulmonary disease (25%, 23%, 27%, 32%).…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 22935
    “…Intergroup comorbidity distribution was similar for hypertension (55%), diabetes (30%), chronic pulmonary disease (21%), thyroid disease (17%) and differed (p<.05) in categories 3[2,5] vs 5[3,6] among obesity (29 vs 48%, BMI 28[24,33] vs 31[26,36]), iron deficiency anemia (21 vs 41%) coagulation disease (15 vs 35%), and renal failure (17 vs 31%). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 22936
    por Chopra, Karishma A.
    Publicado 2023
    “…However, idiopathic cases, although rare, do occur in elderly patients and should be a diagnosis of exclusion after thorough investigation. 76-year-old female with a history of chronic kidney disease, anemia of chronic disease, and hypertension presented with fatigue. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 22937
    “…This group also had a higher odds of having a Charlson comorbidity index of 5 or more (38.73% vs 27.79%, P<0.001) and having concomitant comorbidities like congestive heart failure (20.38% vs 15.55%; P<0.001), chronic kidney disease (24.7% vs 19.65%; P<0.001), COPD (18.11% vs 14.69%; P=0.004), and anemia (32.85% vs 19.91%; P<0.001) compared to group without AI. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 22938
    “…The blood tests showed normocytic anemia (Hb 113 g/L, N>130), low TSH (< 0.01 mUI/L), and elevated free T4 (74.1 pmol/L) and T3 (22.5 pmol/L). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 22939
  20. 22940
    “…From these, 16 individual conditions were included in the meta-analyses, and we identified 10 comorbid conditions to have negative effects on overall prognostic outcomes: DM (HR 1.16, 95% CI 1.11, 1.22), COPD (HR 1.31, 95% CI 1.23, 1.39), CKD (HR 1.18, 95% CI 1.14, 1.23, stroke (HR 1.25, 95% CI 1.17, 1.31), IHD (HR 1.17, 95% CI 1.11, 1.23), anemia (HR 1.42, 95% CI 1.14, 1.78), cancer (HR 1.17, 95% CI 1.04, 1.32), atrial fibrillation (HR 1.25, 95% CI 1.01, 1.54), dementia (HR 1.19, 95% CI 1.03, 1.36) and depression (HR 1.17, 95% CI 1.04, 1.31). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS